24,420 Shares in Trupanion, Inc. $TRUP Acquired by Saranac Partners Ltd

Saranac Partners Ltd purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,420 shares of the financial services provider’s stock, valued at approximately $605,000. Saranac Partners Ltd owned approximately 0.06% of Trupanion at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Kelleher Financial Advisors bought a new position in Trupanion in the third quarter valued at about $74,000. Kemnay Advisory Services Inc. bought a new stake in shares of Trupanion during the fourth quarter worth approximately $64,000. Parallel Advisors LLC lifted its holdings in Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares during the period. Quantbot Technologies LP acquired a new stake in Trupanion during the 2nd quarter worth $89,000. Finally, Advisory Services Network LLC acquired a new stake in Trupanion during the 3rd quarter worth $160,000.

Insider Transactions at Trupanion

In other news, CFO Fawwad Qureshi sold 6,177 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the transaction, the chief financial officer directly owned 2,081 shares of the company’s stock, valued at $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,603 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the transaction, the chief operating officer owned 33,065 shares of the company’s stock, valued at approximately $717,179.85. The trade was a 9.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 18,294 shares of company stock valued at $412,129. 5.58% of the stock is currently owned by company insiders.

Trupanion Stock Performance

Shares of TRUP stock opened at $31.10 on Monday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $48.48. The company’s 50 day moving average price is $26.32 and its two-hundred day moving average price is $26.02. The company has a market capitalization of $1.36 billion, a P/E ratio of 58.68, a price-to-earnings-growth ratio of 2.10 and a beta of 1.39.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period last year, the business posted $0.22 earnings per share. On average, analysts expect that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Stifel Nicolaus upped their price target on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Finally, Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $41.80.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.